| 聂晓静,白荷荷,韩小年.石棉肺合并肺部铜绿假单胞菌感染患者的药学监护[J].中国药事,2017,(9):984-987 |
| 石棉肺合并肺部铜绿假单胞菌感染患者的药学监护 |
| Pharmaceutical Care for One Patient with Asbestosis and Pseudomonas Aeruginosa Infection |
| 投稿时间：2017-02-16 |
| DOI：10.16153/j.1002-7777.2017.09.004 |
| 中文关键词: 药学监护 石棉肺 铜绿假单胞菌感染 不良反应 合理用药 |
| 英文关键词: pharmaceutical care asbestosis pseudomonas aeruginosa infection adverse drug reaction rational drug use |
| 基金项目: |
|
| 摘要点击次数: 849 |
| 全文下载次数: 467 |
| 中文摘要: |
| 目的：探讨肺部铜绿假单胞菌感染患者抗感染治疗过程中的药学服务实践。方法：临床药师参与1例石棉肺合并肺部铜绿假单胞菌感染患者的抗感染治疗全过程，从药物选择、给药剂量、给药间隔等方面优化抗感染治疗方案，并密切监测药品不良反应。结果：患者病情得到有效控制，治疗29日后出院。结论：临床药师对患者抗感染治疗进行个体化用药监护，适当干预，协同临床优化治疗方案，保障用药安全、有效、合理。 |
| 英文摘要: |
| Objective:To discuss the pharmaceutical care practice for a patient with pseudomonas aeruginosa infection in the process of anti-infective therapy. Methods:Clinical pharmacists participated in the whole antiinfective therapy of a patient with asbestosis and pseudomonas aeruginosa infection in order to optimize the therapeutic regimen in respects of drug selection, drug dosage, and the interval of medication. Moreover, the adverse drug reactions were intensively monitored. Results:The Patient was cured and discharged 29 days after the therapy. Conclusions:Clinical pharmacists should provide individualized anti-infective therapy and appropriate intervention for the patients together with the clinically optimized treatment programs to guarantee safe, effective and reasonable drug use. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |